Mostrar el registro sencillo del ítem

dc.contributor.authorSánchez García, Isidro Javier
dc.contributor.authorBrown, Geoffrey
dc.date.accessioned2018-05-25T14:08:15Z
dc.date.available2018-05-25T14:08:15Z
dc.date.issued2015-12-22
dc.identifier.citationBrown, G., Sánchez-García, I. (2015). Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?. Oncotarget, 6 (41), 43326-43341. Retrieved from Web of Science database.es_ES
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10366/137543
dc.description.abstract[EN] Within the past years there have been substantial changes to our understanding of haematopoiesis and cells that initiate and sustain leukemia. Recent studies have revealed that developing haematopoietic stem and progenitor cells are much more heterogeneous and versatile than has been previously thought. This versatility includes cells using more than one route to a fate and cells having progressed some way towards a cell type retaining other lineage options as clandestine. These notions impact substantially on our understanding of the origin and nature of leukemia. An important question is whether leukemia stem cells are as versatile as their cell of origin as an abundance of cells belonging to a lineage is often a feature of overt leukemia. In this regard, we examine the coming of age of the "leukemia stem cell" theory and the notion that leukemia, like normal haematopoiesis, is a hierarchically organized tissue. We examine evidence to support the notion that whilst cells that initiate leukemia have multi-lineage potential, leukemia stem cells are reprogrammed by further oncogenic insults to restrict their lineage decision-making. Accordingly, evolution of a sub-clone of lineage-restricted malignant cells is a key feature of overt leukemia.es_ES
dc.description.sponsorshipEuropean Commision (EC). Funding FP7/SP1/ENV. Project Code: 282891
dc.description.sponsorshipEuropean Commision (EC). Funding FP7/SP3/PEOPLE. Project Code: 315902
dc.description.sponsorshipNational Institutes of Health (NIH)/National Cancer Institute.Projecto Code: 1R01CA109335-01A1
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherImpact Journalses_ES
dc.rightsAttribution-NonCommercial-NoDerivs 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectHaematopoiesises_ES
dc.subjectLeukemiaes_ES
dc.titleIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.18632/oncotarget.6145
dc.subject.unesco2403 Bioquímicaes_ES
dc.identifier.doi10.18632/oncotarget.6145
dc.relation.projectID1R01CA109335-01A1
dc.relation.projectID282891
dc.relation.projectID315902
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 4.0 International